ANTENGENE-B (06996) announced its annual performance, with a adjusted net loss of 233 million yuan in the year, a year-on-year decrease of 23.50%.
Decky Pharmaceuticals-B (06996) announced its annual performance as of December 31, 2025. The group achieved a revenue of RMB 105 million, an increase of 14.56% year-on-year; research and development expenses were RMB 169 million, a decrease of 34.69% year-on-year; a loss of RMB 239 million was incurred during the year, a decrease of 25.10% year-on-year; after adjustment, the loss for the year was RMB 233 million, a decrease of 23.50% year-on-year; loss per share was 0.38 yuan.
ANTENGENE-B (06996) announced the annual performance ending on December 31, 2025. The group achieved a revenue of 105 million yuan (same unit), an increase of 14.56% year-on-year; research and development expenses were 169 million yuan, a decrease of 34.69% year-on-year; the net loss for the year was 239 million yuan, a decrease of 25.10% year-on-year; the adjusted net loss for the year was 233 million yuan, a decrease of 23.50% year-on-year; loss per share was 0.38 yuan.
The announcement stated that the increase in revenue was mainly due to the accelerated contribution from the Chinese mainland, benefiting from the steady increase in market penetration rate and the deepening of commercial cooperation.
Related Articles
CF PHARMTECH (02652) expects to achieve a adjusted net profit of approximately 30-35 million yuan in 2025, with stable business operations and continuous progress in innovative research and development.

US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.
CF PHARMTECH (02652) expects to achieve a adjusted net profit of approximately 30-35 million yuan in 2025, with stable business operations and continuous progress in innovative research and development.
US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


